RVNC   $3.25  -4.13% Market Closed After Close 3.29 1.23%

Revance Therapeutics Inc
Total Cash 232.24M
totalCashPerShare 2.216
EBITDA -192.06M
Total Debt 491.64M
quickRatio 2.866
currentRatio 3.74
Total Revenue 251.18M
debtToEquity
Revenue/Share 2.72
ROA -0.22774
ROE
grossProfits
freeCashflow -151.11M
operatingCashflow -200.76M
earningsGrowth
revenueGrowth 0.202
grossMargins 0.38444
ebitdaMargins -0.76462996
operatingMargins -0.52786
profitMargins -1.1446099
enterpriseValue 871.56M
forwardPE -8.984616
floatShares 91.21M
sharesOutstanding 104.18M
sharesShort 9.19M
sharesShortPriorMonth 7.63M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.69%
Short Ratio help_outline 2.72%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue -1.238
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -304.34M
trailingEps -3.43%
forwardEps -0.65%
enterpriseToEbitda -4.54
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 248
lastUpdated Nov. 6, 2024, 5:25 p.m.